Breaking News

You are here » Indian-Commodity  :  Top News  :  PC Jeweller reports 5% rise in Q1 net profit

11-Aug2018

PC Jeweller reports 5% rise in Q1 net profit

PC Jeweller has reported results for first quarter ended June 30, 2018.

The company has reported 4.50% rise in its net profit at Rs 141.93 crore for the quarter under review as compared to Rs 135.82 crore for the same quarter in the previous year. Total income of the company increased by 14.73% at Rs 2,455.43 crore for Q1FY19 as compared Rs 2,140.17 crore for the corresponding quarter previous year.

PC Jeweller is engaged in manufacturing jewelry products. It offers gold and diamond jewelry and silver articles. Its products include bangles, bracelets, earrings, pendant set, necklaces, pendant, nose rings and rings.


Related News

View all news

Crude oil futures end higher on Friday

Crude oil futures ended higher on Friday on worries about possible impact of US sanctions on Iran's oil exports on crude supply in the market coupled with potential US-Saudi tensions. Prices also supported......

Crude oil futures extend losses on Thursday

Extending previous session losses, crude oil futures ended lower on Thursday due to a sharp jump in US crude inventories last week and on demand growth concerns. The Energy Information Administration's......

Gold futures end higher on Thursday

Gold futures ended higher on Thursday despite rising US dollar on minutes of the Federal Reserve's latest policy meeting indicating that the central bank is staying the course on interest rate hikes.Gold......

Top News

View all news

Bhansali Engineering Polymers reports 33% fall in Q2 net profit

Bhansali Engineering Polymers has reported results for second quarter ended September 30, 2018.The company has reported 32.71% fall in its net profit at Rs 16.89 crore for the quarter under review as compared......

Biocon, Mylan N.V. receive positive CHMP opinion for Ogivri

Biocon and Mylan N.V. have announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Ogivri, a biosimilar......

Lupin Neurosciences receives positive CHMP opinion for NaMuscla

Lupin Neurosciences, a specialty pharma division of Lupin has announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA),......